Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Single Arm Study of Patients Undergoing Posterolateral Lumbar Fusion (Without Interbody) Supplemented With ViviGen Cellular Bone Matrix

NCT04007094 is registered in ClinicalTrials.gov with Ohio State University as lead sponsor.

NCT NCT04007094
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04007094 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Single Arm Study of Patients Undergoing Posterolateral Lumbar Fusion (Without Interbody) Supplemented With ViviGen Cellular Bone Matrix
Lead sponsor
Ohio State University
Phase
Not applicable
Overall status
Terminated
Start date
February 12, 2019
Completion date
January 21, 2022
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

degenerative disc disease, spinal stenosis, spondylolisthesis, spondylosis